{"id":"https://genegraph.clinicalgenome.org/r/961ed9a8-17fa-4769-bb82-cb956dac8eb2v1.1","type":"EvidenceStrengthAssertion","dc:description":"The AGO2 gene is located on chromosome 8 at 8q24.3 and encodes the argonaute RISC catalytic component 2, which is associated with RNA-mediated gene silencing as part of the RNA-inducing silencing complex (RISC). The AGO2 gene was first reported in relation to autosomal dominant Lessel-Kreienkamp syndrome in 2020 (Lessel et al., PMID: 33199684). At least 12 unique variants (including 11 missense and an in-frame deletion) have been reported in over 20 individuals and included in this curation (PMID: 33199684; van der Ven et al., 2021, PMID: 34490615; Stutterd et al., 2022, PMID: 35803560). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. Evidence supporting this gene-disease relationship is primarily case level evidence. Experimental evidence includes biochemical function, a non-human model organism, and functional alteration of non-patient cells. Variants in AGO1 and deletions encompassing AGO1 and AGO3 that belong to the same Argonaute family of proteins as AGO2, have been reported in association with neurodevelopmental phenotypes (Tokita et al., 2015, PMID: 25271087; Schalk et al., 2022, PMID: 34930816). AGO2 has been functionally linked to the FMR1 gene associated with Fragile X syndrome, which displays similar phenotypes to those observed in Lessel-Kreienkamp syndrome (Jin et al., 2004, PMID: 14703574; Pepper et al,. 2009, PMID: 19888420). D. melanogaster Ago2 mutants show neurological deficits and present with defective neuronal branching and synapse formation (19888420). In summary, there is definitive evidence to support the relationship between AGO2 and autosomal dominant Lessel-Kreienkamp syndrome. This relationship has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date 15th September 2023 (SOP Version 9.0).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/961ed9a8-17fa-4769-bb82-cb956dac8eb2","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ec86c06a-f5a3-448d-be53-277bc91d12de","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ec86c06a-f5a3-448d-be53-277bc91d12de_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-01-22T21:05:46.856Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/ec86c06a-f5a3-448d-be53-277bc91d12de_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2023-09-15T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec86c06a-f5a3-448d-be53-277bc91d12de_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec86c06a-f5a3-448d-be53-277bc91d12de_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e35a80f7-e631-4b34-b605-956ae8ab2212","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/649c8cc5-e832-4cd3-88d7-7a87f49cdf1f","type":"Finding","dc:description":"FMRP and Ago2 are a part of the same complex/biochemical pathway\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14703574","rdfs:label":"Biochemical function","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ec86c06a-f5a3-448d-be53-277bc91d12de_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f5952e2-bec3-46ed-907d-7d93df3e5962","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/83a2f6ed-811c-4e87-9351-84a220aee7d4","type":"FunctionalAlteration","dc:description":"see above","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199684","rdfs:label":"CRISPR-mediated knockdown of AGO2 in HEK293T cells "}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ec86c06a-f5a3-448d-be53-277bc91d12de_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4fb603c7-382f-4fad-9bed-f56036ca794c","type":"EvidenceLine","dc:description":"partial phenotypic overlap between human patients and fruit fly larvae, lower level model organism, however rescue supports the role of the Ago2 gene in the phenotype","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9321de98-e654-4ef2-8360-8b7419d5b648","type":"Finding","dc:description":"Different Ago2 null mutant D. Melanogaster larvae show defective neuronal branching patterns and synapse formation. The Ago2 null phenotype at the NMJ was shown to be rescued in D. melanogaster carrying an Ago2 genomic rescue construct. Loss of Ago2 results in increased (Drosophila Fragile X protein) dFMR1 in adult heads. Ago2 is shown to affect synapse formation and neuronal branching and to regulate dFMR1 expression, loss of which causes behavioral and developmental defects in the fly. This may correspond to neurological phenotype observed in LKS\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19888420","rdfs:label":"Non-human model organism","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ec86c06a-f5a3-448d-be53-277bc91d12de_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/93e689f6-99fe-4c4a-8b70-25dbc3cff337","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/93e689f6-99fe-4c4a-8b70-25dbc3cff337_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199684","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a37951a-1080-40fd-8538-81c68b598611","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012154.5(AGO2):c.1070C>T (p.Thr357Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA372322045"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/93e689f6-99fe-4c4a-8b70-25dbc3cff337_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Alters phosphorylation of the C-terminal cluster. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b96c33c9-0efb-40ee-b5e5-ae51d39e0ab9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b96c33c9-0efb-40ee-b5e5-ae51d39e0ab9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199684","allele":{"id":"https://genegraph.clinicalgenome.org/r/2becb2f5-ac02-492d-adb7-b9606933d346","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012154.5(AGO2):c.609T>A (p.His203Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA372323729"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/38d39d16-75e7-45de-836f-219472fa81b7","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/38d39d16-75e7-45de-836f-219472fa81b7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199684","allele":{"id":"https://genegraph.clinicalgenome.org/r/1ee42684-2b16-41e2-937d-6243de0c23dd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012154.5(AGO2):c.602G>T (p.Gly201Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA372323744"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/38d39d16-75e7-45de-836f-219472fa81b7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Alters phosphoylation of the C-terminal cluster. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8c63a60e-2f83-419e-bfa0-6b1a3fb33c6b","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c63a60e-2f83-419e-bfa0-6b1a3fb33c6b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34490615","allele":{"id":"https://genegraph.clinicalgenome.org/r/cb39dc2b-0ab1-4c5b-98de-71074b5f4fd7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012154.5(AGO2):c.575T>C (p.Leu192Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA372323804"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/8c63a60e-2f83-419e-bfa0-6b1a3fb33c6b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Alters phosphorylation of the C-terminal cluster (PMID: 33199684, also found in cases 2 and 3). ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b6e67acc-419f-4004-9e9c-ab1754ee4078","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6e67acc-419f-4004-9e9c-ab1754ee4078_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199684","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a37951a-1080-40fd-8538-81c68b598611"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/b6e67acc-419f-4004-9e9c-ab1754ee4078_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Alters phosphorylation of the C-terminal cluster. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/39106fb8-b21d-4ec0-8928-7745d83dddc4","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39106fb8-b21d-4ec0-8928-7745d83dddc4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199684","allele":{"id":"https://genegraph.clinicalgenome.org/r/270d166b-6fd8-4852-bda7-3453916bf134","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012154.5(AGO2):c.601G>T (p.Gly201Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA372323747"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/39106fb8-b21d-4ec0-8928-7745d83dddc4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Alters phosphorylation of the C-terminal cluster. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8fdd0e73-5ae8-4bd2-bdd9-d1074b5c859e","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8fdd0e73-5ae8-4bd2-bdd9-d1074b5c859e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199684","allele":{"id":"https://genegraph.clinicalgenome.org/r/8daa938c-b74a-48ba-9af3-547360f3ebdf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012154.5(AGO2):c.1091T>C (p.Met364Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA372322001"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/8fdd0e73-5ae8-4bd2-bdd9-d1074b5c859e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Alters phosphorylation of the C-terminal cluster. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3705f4fe-19d1-4d97-b64b-d6e57623aa72","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3705f4fe-19d1-4d97-b64b-d6e57623aa72_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35803560","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a37951a-1080-40fd-8538-81c68b598611"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/3705f4fe-19d1-4d97-b64b-d6e57623aa72_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Alters phosphorylation of the C-terminal cluster (PMID 3199684, also found in cases 8, 9, 11). ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2a64827a-4824-4f55-862b-a91002f9fc14","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a64827a-4824-4f55-862b-a91002f9fc14_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199684","allele":{"id":"https://genegraph.clinicalgenome.org/r/cb39dc2b-0ab1-4c5b-98de-71074b5f4fd7"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/2a64827a-4824-4f55-862b-a91002f9fc14_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Alters phosphorylation of the C-terminal cluster.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a3a221cc-9d13-48c6-b4ff-001f82937d9a","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a3a221cc-9d13-48c6-b4ff-001f82937d9a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199684","allele":{"id":"https://genegraph.clinicalgenome.org/r/1bcf8287-ddf7-47f5-95c6-8085c0ae15b3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012154.5(AGO2):c.541TTC[1] (p.Phe182del)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/995795"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a3a221cc-9d13-48c6-b4ff-001f82937d9a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant located at the base of the L1 linker region which has been previously implicated in the unwinding of RNA duplexes. Authors show reduced phosphorylation of the C-terminal cluster and enhanced binding of p.Phe182del to target mRNAs. there is also an increased clustering of AGO2-positive dendritic P-bodies in dendrites- possibly contributing to neuronal phenotypes in patients. ShRNA mediated silencing of several genes in HEK293 cells was less efficient with AGO2 p.Phe182del than with wt AGO2.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1851450b-149b-4d88-bc6c-92f13b7d7fa1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1851450b-149b-4d88-bc6c-92f13b7d7fa1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199684","allele":{"id":"https://genegraph.clinicalgenome.org/r/14747c9b-8c95-4902-bff3-d87332c62b44","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012154.5(AGO2):c.1099G>C (p.Ala367Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA372321980"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0a23deb1-2c5c-4669-a3dc-e829efb3c57a","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a23deb1-2c5c-4669-a3dc-e829efb3c57a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199684","allele":{"id":"https://genegraph.clinicalgenome.org/r/cb39dc2b-0ab1-4c5b-98de-71074b5f4fd7"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/0a23deb1-2c5c-4669-a3dc-e829efb3c57a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Alters phosphorylation of the C-terminal cluster. \n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/989edced-c37c-4a72-ad79-d976bffb94b5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/989edced-c37c-4a72-ad79-d976bffb94b5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199684","allele":{"id":"https://genegraph.clinicalgenome.org/r/39df498d-a90d-4d02-948a-093d2f063358","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012154.5(AGO2):c.1717G>A (p.Gly573Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA372317964"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/da0ad3f4-1d61-4c45-a418-86011cac43a1","type":"EvidenceLine","dc:description":"Assigned de novo pts as mother has a de novo occurrence of the variant (15% mosaicism)-confirmed de novo can be applied here at SDGCEP discussion/review","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da0ad3f4-1d61-4c45-a418-86011cac43a1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199684","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a37951a-1080-40fd-8538-81c68b598611"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/da0ad3f4-1d61-4c45-a418-86011cac43a1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Alters phosphorylation of the C-terminal cluster. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b85e294e-ec91-4869-8af4-ade184df17a3","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b85e294e-ec91-4869-8af4-ade184df17a3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199684","allele":{"id":"https://genegraph.clinicalgenome.org/r/8daa938c-b74a-48ba-9af3-547360f3ebdf"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/b85e294e-ec91-4869-8af4-ade184df17a3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Alters phosphorylation of the C-terminal cluster. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b7109667-38a6-4fb7-a79c-b6672ca2dc0d","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7109667-38a6-4fb7-a79c-b6672ca2dc0d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199684","allele":{"id":"https://genegraph.clinicalgenome.org/r/1ee42684-2b16-41e2-937d-6243de0c23dd"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/b7109667-38a6-4fb7-a79c-b6672ca2dc0d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Alters phosphorylation of the C-terminal cluster. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":7679,"specifiedBy":"GeneValidityCriteria10","strengthScore":13.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Srpz9a4oUZU","type":"GeneValidityProposition","disease":"obo:MONDO_0030897","gene":"hgnc:3263","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ec86c06a-f5a3-448d-be53-277bc91d12de-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}